Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-17 Orwin John A Director Grant or award +4,500 22,375
2023-05-17 Orwin John A Director Grant or award · Stock option (right to buy) +13,500 13,500
2023-05-17 Squarer Ron Director Grant or award +4,500 22,375
2023-05-17 Squarer Ron Director Grant or award · Stock option (right to buy) +13,500 13,500
2023-05-17 Bruhn Suzanne Louise Director Grant or award +4,500 15,750
2023-05-17 Bruhn Suzanne Louise Director Grant or award · Stock option (right to buy) +13,500 13,500
2023-05-11 Calvin Sandra SVP, Chief Accounting Officer Sale 10b5-1 −122 $16.12 $2K 42,247
2023-05-10 Cline Christopher R. Chief Financial Officer Sale −455 $16.59 $8K 51,031
2023-05-10 REED ELIZABETH E SVP, GC & Corporate Secretary Sale 10b5-1 −825 $16.59 $14K 56,611
2023-05-10 ROTE WILLIAM E. Senior Vice President, R&D Sale 10b5-1 −825 $16.59 $14K 59,211
2023-05-10 Calvin Sandra SVP, Chief Accounting Officer Sale 10b5-1 −436 $16.59 $7K 42,369
2023-04-11 Cline Christopher R. Chief Financial Officer Sale −47 $21.49 $1K 51,486
2023-02-02 Calvin Sandra SVP, Chief Accounting Officer Sale −360 $22.42 $8K 42,805
2023-02-01 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −2,590 $22.25 $58K 57,436
2023-02-01 ROTE WILLIAM E. Senior Vice President, R&D Sale −2,590 $22.25 $58K 60,036
2023-02-01 Heerma Peter Chief Commercial Officer Sale −1,779 $21.75 $39K 82,069
2023-02-01 Cline Christopher R. Chief Financial Officer Sale −1,588 $21.75 $35K 51,533
2023-02-01 Dube Eric M Chief Executive Officer Sale −8,196 $22.25 $182K 237,150
2023-02-01 Calvin Sandra SVP, Chief Accounting Officer Sale −1,671 $21.75 $36K 43,165
2023-01-31 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award +20,250 60,026

Page 27 of 51 · 1,020 trades